Skip to main content
. 2022 Feb 15;8:683445. doi: 10.3389/fcvm.2021.683445

Table 1.

Baseline characteristics of chest pain patients included in this study.

Characteristics AAD
(n = 96)
Controls(n = 249) P-value
Age, mean (range) 59.1 (35–85) 60.3 (40–92) 0.45
Male sex, n (%) 53 (55.2) 128 (51.4) 0.53
Medical history and risk factors, n (%)
Hypertension 72 (75.0) 129 (51.8) <0.05
Diabetes 44 (45.8) 109 (43.8) 0.62
Stroke 28 (29.2) 80 (32.1) 0.60
Hyperlipidemia 48 (50.0) 135 (54.2) 0.48
Smoking 55 (57.3) 125 (50.2) 0.24
Marfan syndrome 12 (12.5) 1 (0.4) <0.01
Atrial fibrillation 28 (29.2) 63 (25.3) 0.47
Valvulopathy 20 (20.8) 42 (16.9) 0.39
Diagnosis, n (%)
TAAD 42 (43.8) / /
TBAD 54 (56.3) / /
IH / 10 (4.0) /
AMI / 63 (25.3) /
PE / 42 (16.9) /
Angina / 66 (26.5) /
Others / 68 (27.3) /
Biochemical and hematological data, mean ±SD
Glucose, mg/dL 130.3 ± 52.4 125.4 ± 44.2 0.42
Creatinine, μmol/L 148.7 ± 33.6 142.9 ± 40.7 0.36
Uric acid, mg/dL 6.1 ± 2.4 5.9 ± 2.9 0.37
Cholesterol, mg/dL 178.3 ± 39.2 183.2 ± 29.9 0.72
Triglycerides, mg/dL 182.1 ± 88.4 189.1 ± 79.2 0.60
AST, U/L 28.2 ± 13.4 30.2 ± 20.2 0.13
ALT, U/L 38.3 ± 16.7 39.6 ± 26.3 0.22
Bilirubin, mg/dL 1.9 ± 1.6 1.8 ± 0.8 0.82
Hematocrit, % 41.3 ± 6.3 39.4 ± 5.6 0.63
Platelets, 103/μL 248.3 ± 56.4 256.6 ± 47.2 0.20
Leukocytes, 103/μL 6.4 ± 3.4 6.8 ± 3.9 0.74
Lymphocytes, % 26.3 ± 9.2 27.5 ± 8.4 0.20
Neutrophils, % 74.4 ± 18.3 73.9 ± 19.8 0.48
Monocytes, % 8.8 ± 4.2 9.0 ± 7.3 0.33
D-dimer, ng/ml 2080.5 ± 1131.9 1867.3 ± 2007.3 <0.05

AAD, acute aortic dissection; TAAD, type A aortic dissection; TBAD, type B aortic dissection; IH, intramural hematoma; AMI, acute myocardial infarction; PE, pulmonary embolism; SD, standard deviation; AST, aspartate transaminase; ALT, alanine aminotransferase.